PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer
2024 · Journal of Experimental & Clinical Cancer Research · 15 citations
https://doi.org/10.1186/s13046-024-03080-1
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
422
Citations
5
h-index
5
i10-index
Silvia Brugiapaglia is an academic researcher from University of Turin. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Immunotherapy and Immune Responses. The author has an h-index of 5, co-authored 15 publications.
ORCID: 0000-0002-8159-0449https://doi.org/10.1186/s13046-024-03080-1
https://doi.org/10.1007/s10238-023-01236-5
Click to start Chat